Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company Radicle Medical Marijuana Inc. has received Health Canada approval for its production facility expansion project. According to the update, the approval effectively doubles Radicle’s production footprint, significantly increasing its yearly capacity to 6,000 kilograms. “We are thrilled with the continued growth…
INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its Co-Founder and CEO RJ Tesi, M.D. will present at the Cambridge Healthcare Institute’s Seventh Annual Immuno-Oncology Summit. The event is taking place in Boston from August 5 through…
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning announced that its CLR Roasters has hired 35-year industry veteran Omar Peraza to lead the company’s food service expansion. According to the update, Peraza holds a global view of all aspects of the coffee industry, and his key…
Lifestyle-oriented cannabis company Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) today announced the completion of its previously disclosed acquisition of Spring Oaks Greenhouses, Inc., per the terms detailed on July 29, 2019. According to the update, the acquisition brings GGB’s ability to operate dispensaries up to 47 across three key states that include Nevada,…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular augmented reality interactive entertainment games and toys in China, today announced the July 30, 2019 closing of its underwritten initial public offering (“IPO”). According to the update, the IPO consisted of 2,000,000 ordinary shares priced at $4 each, before underwriting discounts…
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced it has initiated the first phase of branding its lead drug candidate, Oncoprex(TM) immunogene therapy, and has completed and submitted non-proprietary drug name selections to the American Medical Association’s United States Adopted Names (“USAN”) Council. According to the update, Genprex will, upon receipt of USAN…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today reported on its existing technology licensees that have entered definitive contracts to use its revolutionary DehydraTECH(TM) absorption technology within their existing and emerging brands. “The first half of 2019 delivered a period of unprecedented achievements for Lexaria. We signed more license…
Green Growth Brands (CSE: GGB) (OTCQB: GGBXF), a lifestyle-oriented cannabis company, on Monday announced an amendment to the share purchase agreement dated June 3, 2019 with Spring Oaks Greenhouses, Inc. Per the amended agreement, GGBXF will acquire all of the issued and outstanding shares of capital stock of Spring Oaks. According to the amendment, the…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, recently obtained approval from Health Canada for the licensing of all of the company’s Phase 4A buildout plans, increasing its total licensed production capacity to 61,000 kg. per year (http://ibn.fm/jGAdq). An article discussing the company reads, “Once fully…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, remains dedicated to maintaining its high standards in the midst of a growing cannabis supply gap. An article discussing the company reads, “TGOD is one of three organic cannabis growers in Canada. No synthetic pesticides or fertilizers are used in…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has entered into an advance payment and purchase agreement with 703454 N.B. Inc. (carrying on business as 1812 Hemp). In accordance with the agreement, OGI will pre-fund hemp purchases to receive access to…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the initial sale of its revolutionary BaroShear(TM) K45 processing system. According to the update, the novel instrument system is based on the company’s proprietary Ultra Shear Technology(TM)…
INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its Director of Neuroscience, C.J. Barnum, and Co-Founder and CEO, R.J. Tesi, M.D., will present at the 17th Annual Congress of International Drug Discovery Science & Technology. The event, scheduled…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its entry into a contract services agreement with a multi-billion biotherapeutics company to enhance the manufacturing process of one of their candidate protein drugs. Per the update,…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced a multi-faceted expansion of its relationship with Hill Street Beverage Company Inc. (TSX.V: BEER). According to the update, the companies have entered into a 10-year Joint Manufacturing Partnership (“JMP”) to produce DehydraTECH(TM) commercial products under a new brand, which will…
Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An article discussing the company reads, “One of the delivery challenges is the amount of CBD waste created, because the human…
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that PharmHouse Inc., its 49 percent-owned joint venture, has received a cultivation license from Health Canada. According to the update, PharmHouse will immediately commence operations in 190,000 sq. ft of licensed nursery infrastructure. In addition, the company plans to ramp up its entire 1.3 million…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently unveiled its plan to enter the global hemp-CBD market by announcing the launch of its Global Strategic Hemp Division. An article discussing the company’s entrance into the global hemp-CBD market reads, “TGOD estimates that the global CBD market will reach…
INmune Bio (NASDAQ: INMB) is an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, such as Alzheimer’s disease (“AD”). A recent article discussing the company reads, “An association between inflammation and Alzheimer’s disease has long been established. Until present, however, this link and the way in which…
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company, this morning announced entry of its wholly owned subsidiary, Khrysos Industries, into a one year supply and processing agreement to produce water soluble CBD Isolate, which contains no THC and is expected to generate revenues of $19 million. According to the update, shipping under the agreement…